These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37405389)

  • 21. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Status of Clinical Trials on Tau Immunotherapies.
    Ji C; Sigurdsson EM
    Drugs; 2021 Jul; 81(10):1135-1152. PubMed ID: 34101156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies.
    Montalbano M; Majmundar L; Sengupta U; Fung L; Kayed R
    Brain Pathol; 2023 Jan; 33(1):e13112. PubMed ID: 36054524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical appraisal of tau-targeting therapies for primary and secondary tauopathies.
    Imbimbo BP; Ippati S; Watling M; Balducci C
    Alzheimers Dement; 2022 May; 18(5):1008-1037. PubMed ID: 34533272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
    Samimi N; Sharma G; Kimura T; Matsubara T; Huo A; Chiba K; Saito Y; Murayama S; Akatsu H; Hashizume Y; Hasegawa M; Farjam M; Shahpasand K; Ando K; Hisanaga SI
    Neurobiol Aging; 2021 Dec; 108():72-79. PubMed ID: 34536819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies.
    Lozupone M; Dibello V; Sardone R; Castellana F; Zupo R; Lampignano L; Bortone I; Stallone R; Altamura M; Bellomo A; Daniele A; Solfrizzi V; Panza F
    Expert Opin Drug Discov; 2023 May; 18(5):515-526. PubMed ID: 37042028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.
    Wagshal D; Sankaranarayanan S; Guss V; Hall T; Berisha F; Lobach I; Karydas A; Voltarelli L; Scherling C; Heuer H; Tartaglia MC; Miller Z; Coppola G; Ahlijanian M; Soares H; Kramer JH; Rabinovici GD; Rosen HJ; Miller BL; Meredith J; Boxer AL
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):244-50. PubMed ID: 24899730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.
    Lasagna-Reeves CA; Castillo-Carranza DL; Jackson GR; Kayed R
    Curr Alzheimer Res; 2011 Sep; 8(6):659-65. PubMed ID: 21605039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The therapeutic landscape of tauopathies: challenges and prospects.
    Cummings JL; Gonzalez MI; Pritchard MC; May PC; Toledo-Sherman LM; Harris GA
    Alzheimers Res Ther; 2023 Oct; 15(1):168. PubMed ID: 37803386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.
    Jangampalli Adi P; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166162. PubMed ID: 33940164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tauopathies.
    Devi G
    Handb Clin Neurol; 2023; 196():251-265. PubMed ID: 37620072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disentangling tau: One protein, many therapeutic approaches.
    Lane-Donovan C; Boxer AL
    Neurotherapeutics; 2024 Mar; 21(2):e00321. PubMed ID: 38278659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau PET imaging in neurodegenerative tauopathies-still a challenge.
    Leuzy A; Chiotis K; Lemoine L; Gillberg PG; Almkvist O; Rodriguez-Vieitez E; Nordberg A
    Mol Psychiatry; 2019 Aug; 24(8):1112-1134. PubMed ID: 30635637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.
    Brunden KR; Trojanowski JQ; Lee VM
    Nat Rev Drug Discov; 2009 Oct; 8(10):783-93. PubMed ID: 19794442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.
    Castillo-Carranza DL; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Gerson JE; Singh G; Estes DM; Barrett AD; Dineley KT; Jackson GR; Kayed R
    J Neurosci; 2014 Mar; 34(12):4260-72. PubMed ID: 24647946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies.
    Wang R; Lu KP; Zhou XZ
    J Neurochem; 2023 Sep; 166(6):904-914. PubMed ID: 37638382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies.
    Kim SH; Farrell K; Cosentino S; Vonsattel JG; Faust PL; Cortes EP; Bennet DA; Louis ED; Crary JF
    J Neuropathol Exp Neurol; 2021 Sep; 80(9):835-843. PubMed ID: 34363663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroprotective treatment of tauopathies].
    Respondek G; Krey L; Huber M; Pflugrad H; Wegner F; Höglinger GU
    Nervenarzt; 2021 Dec; 92(12):1227-1238. PubMed ID: 34652482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.